You are here

  • Home
  • Archive
  • Volume 10, Issue 5
  • Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al

Citation Tools

Article menu

Download PDFPDF

Letter
Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Viswanathan VS, Khorrami M, Jazieh K, et al
Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al
Journal for ImmunoTherapy of Cancer 2022;10:e005086. doi: 10.1136/jitc-2022-005086